ImageneBio (IMA) Income Statement: Revenue & Earnings

ImageneBio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

ImageneBio, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	3.50	7.96	15.62	30.99
Cost of Revenue	0.00	0.00	0.00	0.00
Gross Profit	3.50	9.16	15.62	30.99
Operating Expenses
Research & Development	32.11	21.93	64.32	47.11
Selling, General & Administrative	8.39	7.96	22.20	18.02
Operating Expenses	40.50	29.89	86.52	65.12
Operating Income	-37.00	-21.93	-70.90	-34.14
Other Income/Expense
Interest Income	0.37	1.19	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00
Other Income/Expense	0.07	-0.14	2.14	-0.02
Income
Income Before Tax	-36.56	-20.87	-68.77	-34.12
Income Tax Expense	0.01	0.28	0.03	0.00
Net Income	-36.57	-21.15	-68.77	-34.12
Net Income - Continuous Operations	-36.57	-21.15	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00
EBITDA	-35.47	-18.83	-70.15	-33.57
EBIT	-37.00	-21.93	-70.90	-34.12
Depreciation & Amortization	1.53	3.10	0.00	0.50
Earnings Per Share
Basic EPS	-4.00	-3.00	-2.00	-1.00
Diluted EPS	-4.00	-3.00	-2.00	-1.00
Basic Shares Outstanding	11.18	11.18	36.19	27.98
Diluted Shares Outstanding	11.18	11.18	36.19	27.98